- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/84 - Nitrogen atoms
Patent holdings for IPC class C07D 239/84
Total number of patents in this class: 295
10-year publication summary
|
14
|
28
|
20
|
16
|
24
|
27
|
24
|
25
|
18
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Aic246 AG & Co. KG | 33 |
17 |
| Neupharma, Inc. | 72 |
14 |
| Cornell University | 3307 |
11 |
| ArQule, Inc. | 135 |
9 |
| Blueprint Medicines Corporation | 234 |
8 |
| Gilead Sciences, Inc. | 2038 |
8 |
| HMI Medical Innovations, LLC | 16 |
8 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2856 |
7 |
| Merck Patent GmbH | 5818 |
6 |
| Araxes Pharma LLC | 92 |
6 |
| Institute of Organic Chemistry and Biochemistry of the AS CR, v.v.i. | 13 |
6 |
| Eisai R&D Management Co., Ltd. | 1231 |
6 |
| Abbisko Therapeutics Co., Ltd. | 109 |
6 |
| Merck Sharp & Dohme LLC | 3742 |
5 |
| Novartis AG | 10829 |
4 |
| Bristol-myers Squibb Company | 4884 |
4 |
| The Regents of the University of California | 19943 |
4 |
| Merck Sharp & Dohme Corp. | 2190 |
4 |
| Pfizer Inc. | 3380 |
4 |
| Convergene LLC | 11 |
4 |
| Other owners | 154 |